Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Keywords » - entrée « Host-Pathogen Interactions (MeSH) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Host-Parasite Interactions (MeSH) < Host-Pathogen Interactions (MeSH) < Host-Pathogen Interactions (drug effects)  Facettes :

List of bibliographic references indexed by Host-Pathogen Interactions (MeSH)

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000476 (2021) Angela Patrì [Italie] ; Maria Vargas [Italie] ; Pasquale Buonanno [Italie] ; Maria Carmela Annunziata [Italie] ; Daniela Russo [Italie] ; Stefania Staibano [Italie] ; Giuseppe Servillo [Italie] ; Gabriella Fabbrocini [Italie]From SARS-CoV-2 hematogenous spreading to endothelial dysfunction: clinical-histopathological study of cutaneous signs of COVID-19.
000576 (2021) Tobias Welte [Allemagne] ; Lucy J. Ambrose [Royaume-Uni] ; Gillian C. Sibbring [Royaume-Uni] ; Shehla Sheikh [Royaume-Uni] ; Hana Müllerová [Royaume-Uni] ; Ian Sabir [Royaume-Uni]Current evidence for COVID-19 therapies: a systematic literature review.
000755 (2021) Enrico Pezzarossa ; Marco Ungari [Italie] ; Gioachino Caresana ; Fabio Sagradi ; Leonardo Cimardi ; Angelo Pan ; Sophie Testa ; Sergio Aguggini [Italie] ; Elena Varotti [Italie] ; Giulia Tanzi [Italie] ; Laura Manotti [Italie] ; Giuseppina Ferrero [Italie] ; Marino Daniel Gusolfino [Italie] ; Monica Trombatore [Italie]Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia.
000A77 (2020) James J. Dinicolantonio [Oman] ; Mark Mccarty [États-Unis]Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase.
000B29 (2020) Luis Ayerbe [Royaume-Uni] ; Carlos Risco [Espagne] ; Salma Ayis [Royaume-Uni]The association between treatment with heparin and survival in patients with Covid-19.
000B59 (2020) Siri Göpel [Allemagne] ; Wolfgang Bethge [Allemagne] ; Peter Martus [Allemagne] ; Florian Kreth [Allemagne] ; Thomas Iftner [Allemagne] ; Stefanie Joos [Allemagne] ; Stefanie Döbele [Allemagne] ; Benjamin Mordmüller [Allemagne] ; Peter Kremsner [Allemagne] ; Thomas Ettrich [Allemagne] ; Thomas Seufferlein [Allemagne] ; Michael Bitzer [Allemagne] ; Nisar Malek [Allemagne]Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial.
000E11 (2020) Pradeesh Sivapalan [Danemark] ; Charlotte Suppli Ulrik [Danemark] ; Rasmus Dahlin Bojesen [Danemark] ; Therese Sophie Lapperre [Danemark] ; Josefin Viktoria Eklöf [Danemark] ; Kjell Erik Julius H Kansson [Danemark] ; Andrea Browatzki [Danemark] ; Casper Tidemansen [Danemark] ; Jon Torgny Wilcke [Danemark] ; Julie Janner [Danemark] ; Vibeke Gottlieb [Danemark] ; Howraman Meteran [Danemark] ; Celeste Porsbjerg [Danemark] ; Birgitte Lindegaard Madsen [Danemark] ; Mia Moberg [Danemark] ; Lars Pedersen [Danemark] ; Thomas Lars Benfield [Danemark] ; Jens Dilling Lundgren [Danemark] ; Filip Krag Knop [Danemark] ; Tor Biering-S Rensen [Danemark] ; Muzhda Ghanizada [Danemark] ; Tine Peick Sonne [Danemark] ; Uffe Christian Steinholtz B Dtger [Danemark] ; Sidse Graff Jensen [Danemark] ; Daniel Bech Rasmussen [Danemark] ; Eva Br Ndum [Danemark] ; Oliver Djurhuus Tupper [Danemark] ; Susanne Wiemann S Rensen [Danemark] ; Gitte Alstrup [Danemark] ; Christian Borbjerg Laursen [Danemark] ; Ulla Weinrich M Ller [Danemark] ; Asger Sverrild [Danemark] ; Jens-Ulrik St Hr Jensen [Danemark]Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
000E89 (2020) Ali S. Imami [États-Unis] ; Sinead M. O'Donovan [États-Unis] ; Justin F. Creeden [États-Unis] ; Xiaojun Wu [États-Unis] ; Hunter Eby [États-Unis] ; Cheryl B. Mccullumsmith [États-Unis] ; Kerstin Uvn S-Moberg [Suède] ; Robert E. Mccullumsmith [États-Unis] ; Elissar Andari [États-Unis]Oxytocin's anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach.
001195 (2020) Raquel González [Espagne, Mozambique] ; Laura García-Otero [Espagne, Mozambique] ; Clara Pons-Duran [Espagne] ; Elena Marbán-Castro [Espagne] ; Anna Goncé [Espagne] ; Elisa Llurba [Espagne] ; Maria Del Mar Gil [Espagne] ; Miguel Ngel Rodríguez-Zambrano [Espagne] ; Haily Chen [Espagne] ; Máximo Ramírez [Espagne] ; Azucena Bardají [Espagne, Mozambique] ; Clara Menendez [Espagne, Mozambique]Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
001365 (2020) Seyed Sina Naghibi Irvani [Iran] ; Maryam Golmohammadi [Iran] ; Mohamad Amin Pourhoseingholi [Iran] ; Shervin Shokouhi [Iran] ; Ilad Alavi Darazam [Iran]Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
001504 (2020) Aydincan Akdur [Turquie] ; Emre Karakaya ; Ebru H. Ayvazoglu Soy ; Omar Alshalabi ; Mahir Kirnap ; Hande Arslan ; Gaye Ulubay ; Koray Hekimoglu ; Gokhan Moray ; Mehmet HaberalCoronavirus Disease (COVID-19) in Kidney and Liver Transplant Patients: A Single-Center Experience.
001641 (2020) Carmel M. Mceniery [Royaume-Uni] ; Marie Fisk [Royaume-Uni] ; Karen Miles [Royaume-Uni] ; Fotini Kaloyirou [Royaume-Uni] ; Annette Hubsch [Royaume-Uni] ; Jane Smith [Royaume-Uni] ; Ian B. Wilkinson [Royaume-Uni] ; Joseph Cheriyan [Royaume-Uni]ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
001925 (2020) Paola Sgubbi [Italie] ; Francesco Savoia [Italie] ; Ombretta Calderoni [Italie] ; Rosita Longo [Italie] ; Caterina Stinchi [Italie] ; Michela Tabanelli [Italie]Alopecia areata in a patient with SARS-Cov-2 infection.
001973 (2020) Jonathan Rilinger [Allemagne] ; Winfried V. Kern [Allemagne] ; Daniel Duerschmied [Allemagne] ; Alexander Supady [Allemagne] ; Christoph Bode [Allemagne] ; Dawid L. Staudacher [Allemagne] ; Tobias Wengenmayer [Allemagne]A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
001A01 (2020) Mohammad Bosaeed [Arabie saoudite] ; Ebrahim Mahmoud [Arabie saoudite] ; Mohammad Hussein [Arabie saoudite] ; Ahmad Alharbi [Arabie saoudite] ; Abdulrahman Alsaedy [Arabie saoudite] ; Adel Alothman [Arabie saoudite] ; Majed Aljeraisy [Arabie saoudite] ; Hajar Alqahtani [Arabie saoudite] ; Marwan Nashabat [Arabie saoudite] ; Badriah Almutairi [Arabie saoudite] ; Manar Almaghaslah [Arabie saoudite] ; Omar Aldibasi [Arabie saoudite] ; Sameera Aljohani [Arabie saoudite] ; Abderrezak Bouchama [Arabie saoudite] ; Yaseen Arabi [Arabie saoudite] ; Ahmad Alaskar [Arabie saoudite]A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Host-Pathogen Interactions (MeSH)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Host-Pathogen Interactions (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Host-Pathogen Interactions (MeSH)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021